Renvela - 58468-0131-5 - (SEVELAMER CARBONATE)

Alphabetical Index


Drug Information of Renvela

Product NDC: 58468-0131
Proprietary Name: Renvela
Non Proprietary Name: SEVELAMER CARBONATE
Active Ingredient(s): 2400    mg/1 & nbsp;   SEVELAMER CARBONATE
Administration Route(s): ORAL
Dosage Form(s): POWDER, FOR SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of Renvela

Product NDC: 58468-0131
Labeler Name: Genzyme Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022318
Marketing Category: NDA
Start Marketing Date: 20090812

Package Information of Renvela

Package NDC: 58468-0131-5
Package Description: 15 PACKET in 1 CARTON (58468-0131-5) > 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0131-3)

NDC Information of Renvela

NDC Code 58468-0131-5
Proprietary Name Renvela
Package Description 15 PACKET in 1 CARTON (58468-0131-5) > 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0131-3)
Product NDC 58468-0131
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name SEVELAMER CARBONATE
Dosage Form Name POWDER, FOR SUSPENSION
Route Name ORAL
Start Marketing Date 20090812
Marketing Category Name NDA
Labeler Name Genzyme Corporation
Substance Name SEVELAMER CARBONATE
Strength Number 2400
Strength Unit mg/1
Pharmaceutical Classes Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]

Complete Information of Renvela


General Information